Category: Allergan Inc.Syndicate content

CRM: BSX's gain is STJ's loss | Medtech Wall Street news for the week of March 23, 2015

March 26, 2015 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Boston Scientific's gain is St. Jude Medical's loss; Abiomed soars to new all-time high on FDA nod; Philips mulls 2016 IPO for lighting biz as bidding war heats up; SteadyMed prices $40m IPO well under range; Becton Dickinson to shed assets after CareFusion buy

CRM: Boston Scientific's gain is St. Jude Medical's loss

March 20, 2015 by Brad Perriello

ZMH set to acquire EU approval for $13B Biomet deal | The week in medtech M&A

March 25, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: EU to clear Zimmer's $13B Biomet deal; Philips mulls 2016 IPO for lighting biz as bidding war heats up; Heraeus acquires guidewire maker NeoMetrics; Pyott out after Actavis closes $70B Allergan buyout; Australian PE shop acquires Simplify Medical

Report: EU to clear Zimmer's $13B Biomet deal

March 18, 2015 by MassDevice

Philips mulls 2016 IPO for lighting biz as bidding war heats up

March 20, 2015 by Brad Perriello

Royal Philips says it's considering an initial public offering next year for its legacy lighting business, even as a new suitor emerges from Asia; names ex-Allergan chief Pyott to board.

Philips mulls 2016 IPO for lighting biz as bidding war heats up

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Pyott out after Actavis closes $70B Allergan buyout

March 18, 2015 by Mark Hollmer

Former Allergan CEO David Pyott will not get a seat on the board at Actavis after all, now that their $70 billion merger is done.

Pyott out after Actavis closes $70B Allergan buyout

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

J&J deals Cordis for nearly $2B | The week in medtech M&A

March 4, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: J&J deals Cordis to Cardinal Health for nearly $2B; Cyberonics to buy Italy's Sorin for $1.4B; Boston Scientific to buy Endo's urology portfolio for $1.65B; Nikon pushes into medtech with $400 mln Optos acquisition; Allergan CEO in line for $100M payout from Actavis deal

J&J deals Cordis to Cardinal Health for nearly $2B

March 2, 2015 by Brad Perriello

Report: Allergan CEO in line for $100M payout from Actavis deal

February 25, 2015 by Mark Hollmer

Allergan CEO David Pyott will get about $100 million in severance once his company’s merger with Actavis is completed, according to a news report.

David Pyott

Allergan (NYSE:AGN) Chairman and CEO David Pyott stands to earn $100 million once its multi-billion-dollar merger with Actavis (NYSE:ACT)  is consummated later this year.

CAH top suitor for JNJ's Cordis unit | The week in medtech M&A

February 25, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Cardinal Health top suitor for J&J's Cordis unit; 3M to buy Ivera Medical; Allergan name to live on post Actavis merger; Lumenis in talks to be acquired by Fosun for $480M; Uroplasty, Vision-Sciences set date for merger vote

Report: Cardinal Health top suitor for J&J's Cordis unit

February 23, 2015 by Brian Johnson

Report: J&J's selling its Cordis division